Education
About Us
Working with TipRanks
Follow Us
XP Chemistries AB (SE:XPC)
:XPC
Top Page
XP Chemistries AB
(XPC)
Select Model
Select Model
Rating:44Neutral
Price Target:
kr0.18
▼(-1.67% Downside)
The score is primarily pressured by weak financial performance (very small/volatile revenue, large losses, and continued cash burn), partially offset by a conservative, no-debt balance sheet. Technicals also remain bearish with the stock below key moving averages and a negative MACD, while valuation is constrained by negative earnings and no stated dividend yield.
XP Chemistries AB (XPC) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr55.73M
Dividend YieldN/A
Average Volume (3M)792.79K
Price to Earnings (P/E)―
Beta (1Y)0.58
Revenue GrowthN/A
EPS GrowthN/A
CountrySE
Employees2
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.01
Shares Outstanding313,976,300
10 Day Avg. Volume516,841
30 Day Avg. Volume792,795
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.49
Price to Sales (P/S)37.09
P/FCF Ratio-1.23
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XP Chemistries AB Business Overview & Revenue Model
Company DescriptionXP Chemistries AB, a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.
How the Company Makes Money
XP Chemistries AB Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 311.47K | 283.94K | 663.68K | 1.06M | 279.39K | 37.18K |
| Gross Profit | 177.57K | 328.97K | 335.61K | 488.98K | 149.56K | -486.31K |
| EBITDA | -8.15M | -7.52M | -8.70M | -8.73M | -5.01M | -2.03M |
| Net Income | -7.67M | -7.13M | -8.04M | -7.92M | -4.55M | -2.16M |
Balance Sheet | ||||||
| Total Assets | 40.66M | 22.72M | 27.20M | 30.65M | 34.39M | 5.21M |
| Cash, Cash Equivalents and Short-Term Investments | 18.02M | 2.15M | 7.83M | 15.20M | 21.40M | 2.82M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.09M | 1.16M | 1.51M | 1.58M | 3.09M | 633.64K |
| Stockholders Equity | 39.57M | 21.56M | 25.69M | 29.07M | 31.30M | 4.57M |
Cash Flow | ||||||
| Free Cash Flow | -7.48M | -8.53M | -11.41M | -11.80M | -8.13M | 0.00 |
| Operating Cash Flow | -7.13M | -7.69M | -9.08M | -9.85M | -4.99M | 0.00 |
| Investing Cash Flow | -385.97K | -834.96K | -2.33M | -1.95M | -6.31M | 0.00 |
| Financing Cash Flow | 23.89M | 2.85M | 4.04M | 5.60M | 32.70M | 0.00 |
XP Chemistries AB Peers Comparison
UnderperformOutperform
Sector (61)
SE:XPC
XP Chemistries AB
0.18
0.11
156.34%
DE:NC4
Nexam Chemical Holding AB
0.19
-0.12
-38.85%
DE:5L80
Svenska Aerogel Holding AB
0.07
-0.35
-82.97%
DE:284
Serstech AB
0.04
-0.07
-63.11%
DE:A6X
aXichem AB Class A
0.17
0.09
111.54%
DE:0CF
OrganoClick AB
0.13
-0.08
-37.14%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.